Leptomeningeal Disease

Leptomeningeal disease (LMD) is a serious condition where cancer cells spread to the thin membranes covering the brain and spinal cord, called the leptomeninges, and the fluid surrounding them (cerebrospinal fluid). It is a complication of advanced cancer, often causing a range of neurological symptoms that can develop quickly and require prompt medical attention.

What is Leptomeningeal Disease?

Leptomeningeal disease (LMD) occurs when cancer cells spread to the leptomeninges, which are the delicate membranes that surround and protect your brain and spinal cord. These cancer cells can also float in the cerebrospinal fluid (CSF), the fluid that cushions these vital organs. LMD is a serious complication, usually seen in people with advanced cancer.

Your brain and spinal cord are covered by three layers of protective tissue called meninges. The leptomeninges refer to the two innermost layers: the pia mater and the arachnoid mater. These thin membranes are crucial for protecting your central nervous system and are where cancer cells can establish themselves in LMD. Normally, cerebrospinal fluid (CSF) flows between these layers, providing nutrients and removing waste. In leptomeningeal disease, cancer cells break away from a primary tumor elsewhere in the body and travel through the bloodstream or lymphatic system to reach the CSF. This spread is a form of metastasis, where cancer moves from its original site to a new location. Once in the CSF, these cancer cells can spread widely, forming new tumors along the surface of the brain, spinal cord, and nerve roots. This widespread infiltration disrupts normal brain and spinal cord function, leading to a variety of neurological symptoms that can affect many parts of the body.

Symptoms

Symptoms of leptomeningeal disease vary widely depending on where the cancer cells are affecting the brain, spinal cord, or nerves. Common signs include headaches, confusion, vision problems, weakness or numbness in the limbs, and difficulty walking. These symptoms can develop rapidly and often worsen over time.

When cancer cells affect the brain, you might experience symptoms such as persistent headaches, confusion, memory problems, or changes in your mental state. Some people may also have seizures, difficulty speaking, or problems with their vision, such as double vision or blurred sight. Hearing loss or weakness in facial muscles can also occur, depending on which cranial nerves are involved. If the cancer cells spread along the spinal cord, symptoms often include weakness, numbness, or tingling sensations in your arms or legs. You might find it difficult to walk steadily or maintain your balance. Back pain is also common, and some individuals may experience problems with bladder or bowel control due to nerve compression or damage. Symptoms can also arise from cancer cells affecting the nerves that exit the spinal cord. This can lead to pain, weakness, or numbness in specific areas of the body supplied by those nerves. Because the cancer cells can spread throughout the entire central nervous system, symptoms can be widespread and change as the disease progresses, often developing quickly over days to weeks.

Causes & risk factors

Leptomeningeal disease is almost always a complication of advanced cancer, meaning cancer that has spread from its original site to other parts of the body (metastatic cancer). It is not a primary cancer itself. The most common primary cancers that lead to LMD include breast cancer, lung cancer, melanoma, and certain blood cancers like leukemia and lymphoma.

LMD develops when cancer cells from an existing tumor break away and travel to the central nervous system. These cells then invade the leptomeninges and the cerebrospinal fluid. This process is a form of metastasis, where cancer spreads from one part of the body to another, often indicating a more advanced stage of the disease. While any advanced cancer can potentially lead to LMD, some types are more frequently associated with it. For example, breast cancer and lung cancer are among the most common primary cancers that spread to the leptomeninges. Melanoma, a serious type of skin cancer, also has a higher tendency to spread to the brain and spinal cord coverings. Leukemia and lymphoma, which are cancers of the blood and lymphatic system, can also spread to the leptomeninges. The risk of developing LMD increases as cancer progresses and becomes more advanced, particularly if the original cancer has already spread to other organs or has a known propensity for central nervous system involvement.

How it's diagnosed

Diagnosing leptomeningeal disease typically involves a combination of a neurological exam, imaging tests like magnetic resonance imaging (MRI), and a procedure called a lumbar puncture (spinal tap). These tests help doctors identify cancer cells in the cerebrospinal fluid or detect abnormalities in the brain and spinal cord.

Your doctor will first perform a neurological exam to check your reflexes, muscle strength, sensation, vision, and coordination. This helps identify which parts of your nervous system might be affected by the cancer cells. Based on these findings and your medical history, further diagnostic tests will be ordered to confirm the presence of LMD. Magnetic resonance imaging (MRI) of the brain and spinal cord is a key diagnostic tool. This imaging test uses strong magnets and radio waves to create detailed pictures of your internal organs. Doctors often use a special contrast dye during the MRI to highlight areas where cancer cells may have spread within the leptomeninges, making them more visible. Another crucial test is a lumbar puncture, also known as a spinal tap. During this procedure, a small amount of cerebrospinal fluid (CSF) is carefully collected from your lower back. The CSF is then sent to a lab to be examined for the presence of cancer cells. Sometimes, cancer cells are not found on the first attempt, so repeated lumbar punctures may be necessary to confirm the diagnosis.

Treatment options

Treatment for leptomeningeal disease focuses on managing symptoms, improving quality of life, and slowing the progression of the cancer. Because LMD is a serious condition, treatment is often complex and may involve chemotherapy delivered directly into the spinal fluid, radiation therapy, or targeted therapies.

One common treatment approach is intrathecal chemotherapy, where anti-cancer drugs are injected directly into the cerebrospinal fluid (CSF). This can be done through a lumbar puncture or a small device surgically placed under the scalp called an Ommaya reservoir, which allows for repeated drug delivery. This method helps the drugs reach the cancer cells more effectively, as many chemotherapy drugs given intravenously do not easily cross the blood-brain barrier. Radiation therapy may be used to target specific areas of the brain or spinal cord where cancer cells are causing symptoms. This can help reduce pain, relieve pressure, or improve neurological function. The type and amount of radiation depend on the extent of the disease and your overall health, and it is often used to address localized areas of disease. In some cases, systemic chemotherapy (given intravenously) or targeted therapy drugs may be used, especially if they are known to be effective against the primary cancer and can cross into the central nervous system. If there is a buildup of CSF causing pressure on the brain (hydrocephalus), a shunt may be surgically placed to drain the excess fluid and relieve symptoms, which can significantly improve comfort and function.

Recovery & outlook

The outlook for individuals with leptomeningeal disease is generally serious, as it indicates advanced cancer. While treatments can help manage symptoms, improve quality of life, and sometimes extend life, LMD is typically not curable. The goal of care often shifts to symptom control and maintaining comfort.

The prognosis for leptomeningeal disease varies depending on the type of primary cancer, how widespread the LMD is, and your overall health. Unfortunately, the median survival time for people with LMD is often measured in months, typically ranging from a few weeks to several months, even with treatment. This serious outlook underscores the advanced nature of the disease. Despite the serious outlook, treatment can significantly improve quality of life by reducing symptoms like pain, headaches, and neurological deficits. It can also help to slow the progression of the disease, potentially extending life for some individuals. Your medical team will work with you to create a care plan that balances aggressive treatment with comfort and symptom management, focusing on your personal goals. Ongoing research is exploring new therapies and combinations of treatments to improve outcomes for LMD. It is important to have open discussions with your healthcare team about your treatment goals, potential benefits, and risks, as well as to consider supportive care options to ensure the best possible quality of life throughout the course of the disease.

When to see a doctor

If you have a history of cancer and develop new or worsening neurological symptoms, it is important to see a doctor immediately. Red-flag signs include severe or persistent headaches, sudden confusion, vision changes, new weakness or numbness in your limbs, difficulty walking, or seizures.

These symptoms could indicate that your cancer has spread to the central nervous system, including the leptomeninges. Early evaluation is crucial for proper diagnosis and to begin appropriate management, which can help control symptoms and potentially slow disease progression. Do not delay seeking medical attention if you experience any of these changes. Specifically, be alert for symptoms such as a headache that is different from your usual headaches or that does not improve with typical pain relievers. Any sudden changes in your ability to think clearly, remember things, or speak should also prompt an urgent medical visit, as these can be signs of brain involvement. Other concerning signs include double vision, blurred vision, or loss of vision; new or worsening weakness in an arm or leg; difficulty with balance or coordination; or any new seizure activity. Your doctor can assess your symptoms and recommend the necessary diagnostic tests to determine the cause and initiate timely treatment.

Frequently asked questions

Can leptomeningeal disease be cured?

Leptomeningeal disease is generally not curable because it signifies advanced cancer that has spread extensively within the central nervous system. Treatment focuses on managing symptoms, improving quality of life, and slowing the disease's progression rather than achieving a cure.

How quickly do symptoms of leptomeningeal disease develop?

Symptoms of leptomeningeal disease can develop relatively quickly, often over days to weeks. They can also worsen rapidly as the cancer cells continue to spread and affect more areas of the brain, spinal cord, and nerves, making prompt medical attention important.

Is leptomeningeal disease the same as brain metastases?

No, leptomeningeal disease is different from typical brain metastases. Brain metastases are usually solid tumors that form within the brain tissue itself. LMD involves cancer cells spreading within the cerebrospinal fluid and along the thin membranes (leptomeninges) covering the brain and spinal cord, rather than forming a solid mass within the brain tissue.

What is an Ommaya reservoir and why is it used in LMD treatment?

An Ommaya reservoir is a small, dome-shaped device surgically placed under the scalp, connected to a thin tube that goes into a fluid-filled space in the brain. It is used in LMD treatment to deliver chemotherapy drugs directly into the cerebrospinal fluid (intrathecal chemotherapy) repeatedly and easily, avoiding the need for multiple lumbar punctures.

What kind of doctor treats leptomeningeal disease?

Leptomeningeal disease is typically managed by a team of specialists, which may include oncologists (cancer doctors), neurologists (doctors specializing in the nervous system), neuro-oncologists (specialists in brain and spinal cord cancers), and radiation oncologists. This multidisciplinary approach ensures comprehensive care.

Can leptomeningeal disease be prevented?

Currently, there is no known way to prevent leptomeningeal disease, as it is a complication of advanced cancer. The focus is on early detection and effective treatment of the primary cancer to try and prevent its spread, but once cancer is advanced, LMD can still occur.

Sources

• MedlinePlus — Leptomeningeal Disease
• Mayo Clinic — Leptomeningeal Disease
• Cochrane Library — Leptomeningeal Disease